Clinical trials
Phase 2 Carcinoma, Lobular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 2 |
| Dana-Farber Cancer Institute | 2 |
| Rutgers, The State University of New Jersey | 2 |
| ARCAGY/ GINECO GROUP | 1 |
| Asan Medical Center | 1 |
| Auxilio Mutuo Cancer Center | 1 |
| Blue Earth Diagnostics | 1 |
| Case Comprehensive Cancer Center | 1 |
| Jules Bordet Institute | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Lobular | 22 |
| Breast Neoplasms | 12 |
| Carcinoma, Ductal, Breast | 9 |
| Inflammatory Breast Neoplasms | 5 |
| Carcinoma, Intraductal, Noninfiltrating | 4 |
| Breast Carcinoma In Situ | 3 |
| Breast Neoplasms, Male | 3 |
| Stomach Neoplasms | 2 |
| Carcinoma, Ovarian Epithelial | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.